On Jan. 20, 2023, the Biden Administration announced it will end the public health emergency (and national emergency) declarations on May 11, 2023. This policy watch provides an overview of how health care coverage and access will and won’t change when…
This slideshow examines how cost and insurance affects people’s access to care, including decisions to forgo or delay needed care and access to a usual source of care.
This chart collection examines the latest available data on how health services utilization has changed over the course of the COVID-19 pandemic.
This analysis of 2020 claims data finds that as telehealth use surged as the COVID-19 pandemic hit, the shift toward virtual physician and mental health care did not materially affect how much insurers paid for each patient encounter.
The Health Spending Explorer on the Peterson-KFF Health System Tracker helps users examine five decades worth of numbers documenting expenditures by federal and local governments, private insurers, and individuals on 15 categories of health services, i…
This survey looks at the public’s health care priorities for the new Congress, including price transparency, mental health, abortion, Medicaid, and health costs. It also looks at the public’s views of the main health provisions in the Inflation Reducti…
This analysis details how ACA marketplace premiums are changing from 2022 to 2023, and the impact of subsidies to make them more affordable. Premiums vary based on location and metal level, and t T analysis details how premiums are changing from 2022 t…
This analysis uses 2019 insurance claims data from large employer health plans to assess the total and out-of-pocket costs of emergency department visits, overall and by diagnosis and severity level. It also looks at which services contribute most to t…
If the federal government runs out of money to purchase COVID-19 vaccines, the per-dose price likely would skyrocket and could increase spending on vaccines by billions of dollars a year, a new KFF analysis finds. To date, the federal government has sp…
This analysis illustrates the potential total cost of Pfizer and Moderna COVID-19 vaccines, based on their publicly-announced expected prices, once they enter the U.S. commercial market. It compares the average price paid by the federal government for …
